Fibroblast Growth Factor-21 (FGF21) has been recognized as an important mediator in hepatic lipid metabolism, and suggested as a biomarker for NAFLD. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.